April 2, 2020 - Dr. Robert L. Bard, NYC imaging specialist collaborates with an international group of medical leaders including Dr. Danilo Buonsenso (Rome, Italy) who recently published reports about "ultrasound equipment as an effective replacement of the stethoscope.” Dr. Buonsenso's review presents the valid uses and benefits of Lung Ultrasound in identifying respiratory disorders that may be associated with Covid-19.
Currently, front line physicians in Italy and Spain are reportedly triaging with portable ultrasound units that reduce logistical problems of a chaotic environment and healthcare worker exposure. Since imaging with CT or ultrasound is not diagnostic, determining who needs hospitalization is essential in a pandemic overwhelming medical providers. Dr. Buonsenso, at the viral epicenter in Rome, uses sonograms to decide who requires a CT scan.
Dr. Bard reviews international healthcare and technology updates as part of his continued research in the radiological society. This includes Dr. Buonsenso's national reports about the Covid crisis and the expanded use of lung ultrasound as part of his investigation of children as clinically unaffected carriers. “The global pandemic demands effective answers toward a cure as well as protection of healthcare workers on duty", says Dr. Bard. "I have the highest regard for the European approach to problem solving both clinically and technologically… applying Dr. Buonsenso’s concept makes perfect sense to me and carries great value in our war against Covid-19.”
Ultrasound probes study the lungs between the ribs to read the lung surface where most Covid pathology is situated |
In a recent telehealth conference, Dr. Bard explains how ultrasound probes study the lungs between the ribs to read the lung surface where most Covid pathology is situated. (Image 1) Portable units have the advantage of containment within a sterile sleeve, preventing accidental viral spread to imaging equipment necessitating full decontamination procedures. All clinical imaging was correlated with the patient’s oxygen saturation and clinical setting. The virus has known cardiac toxicity so the same sonogram unit may image the heart for fluid buildup and weakened contraction. This may differentiate heart failure from pulmonary infection in some cases which may have similar clinical presentations.
Dr. Robert Bard currently runs a private imaging center in NYC specializing in advanced 3-D sonography to detect cancer tumors and other health disorders. He lectures in medical conferences worldwide, runs a cancer awareness program for first responders and is also a publisher of countless educational books and articles about cancer imaging and other health/wellness related materials.
Dr. Bard maintains an active role in supporting the medical community by contributing relevant articles to major health magazines, medical journals and news organizations pertaining to current health concerns. His recent projects include advocating and inserting TELEMEDCINE in the medical community as a safe alternative for patients. Other projects include an upcoming collaborative textbook series on Covid-19 with a list of top experts in the field. Dr. Bard is also the president of the AngioFoundation (501c3), as philanthropic organization dedicated to funding and supporting public education about current treatment protocols worldwide.
Dr. Bard maintains an active role in supporting the medical community by contributing relevant articles to major health magazines, medical journals and news organizations pertaining to current health concerns. His recent projects include advocating and inserting TELEMEDCINE in the medical community as a safe alternative for patients. Other projects include an upcoming collaborative textbook series on Covid-19 with a list of top experts in the field. Dr. Bard is also the president of the AngioFoundation (501c3), as philanthropic organization dedicated to funding and supporting public education about current treatment protocols worldwide.
Actively practicing as a Pediatrician from Gemelli University Hospital in Italy, Dr. Danilo Buonsenso received his medical degree from the Catholic University of the Sacred Heart in Rome in 2010. He was a resident in The School of Pediatrics in the Catholic University of the Sacred Heart till 2016. From January 2016, he was a Head Director of a social and health developing program in the community of Bureh Town, Sierra Leone which aimed to bring medical and social support to fragile populations. At present, he is a Pediatrician at the Department of Woman and Child Health and Publich Health at the Gemelli University Hospital, Rome, Italy.
Dr. Buonsenso's basic personal skills are in Infectious diseases, Pediatric ER and Pediatric Ultrasonography. He has published almost 50 papers in various journals of Pediatrics and has received various grants such as a Grant as a young collaborator by The Italian Minister of Health for the Bando Ricerca Finalizzata 2018, on the role of NGF on brain function recovery after severe brain injury. (Source)
About Dr. Klaus Lessnau
Dr. Klaus Lessnau specializes in Pulmonology, Sleep Medicine, Insomnia Testing, Sleep Apnea Testing, Pulmonary Function Testing. He is a highly regarded Pulmonologist and a Sleep Medicine specialist with the 14 Street Medical Arts team in NYC. Dr. Lessnau is board certified in Pulmonology, Bronchology, Sleep Medicine Disorders and is a Critical Care doctor with over 30 years of experience. He is also serving as a Director of Critical Care Medicine at Lennox Hill Hospital.
# # #
References
1) Is there a role for lung ultrasound during the COVID‐19 pandemic? - Danilo Buonsenso https://onlinelibrary.wiley.com/doi/abs/10.1002/jum.15284
2) The Lancet: COVID-19 outbreak: less stethoscope, more ultrasound" https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(20)30120-X/fulltext
Danilo Buonsenso | Davide Pata | Antonio Chiaretti - Published:March 20, 2020
3) Dr. Klaus Lessnau, author of "Atlas of Chest Sonography" (Springer 2003) https://link.springer.com/book/10.1007%2F978-3-662-05278-5
Disclaimer & Copyright Notice: The materials provided on this website are copyrighted and the intellectual property of the publishers/producers (The NY Cancer Resource Alliance/IntermediaWorx inc. and Bard Diagnostic Research & Educational Programs). It is provided publicly strictly for informational purposes within non-commercial use and not for purposes of resale, distribution, public display or performance. Unless otherwise indicated on this web based page, sharing, re-posting, re-publishing of this work is strictly prohibited without due permission from the publishers. Also, certain content may be licensed from third-parties. The licenses for some of this Content may contain additional terms. When such Content licenses contain additional terms, we will make these terms available to you on those pages (which his incorporated herein by reference).The publishers/producers of this site and its contents such as videos, graphics, text, and other materials published are not intended to be a substitute for professional medical advice, diagnosis, or treatment. For any questions you may have regarding a medical condition, please always seek the advice of your physician or a qualified health provider. Do not postpone or disregard any professional medical advice over something you may have seen or read on this website. If you think you may have a medical emergency, call your doctor or 9-1-1 immediately. This website does not support, endorse or recommend any specific products, tests, physicians, procedures, treatment opinions or other information that may be mentioned on this site. Referencing any content or information seen or published in this website or shared by other visitors of this website is solely at your own risk. The publishers/producers of this Internet web site reserves the right, at its sole discretion, to modify, disable access to, or discontinue, temporarily or permanently, all or any part of this Internet web site or any information contained thereon without liability or notice to you.
©Copyright Intermedia Worx Inc./Prevention 101. All Rights Reserved.